Clinical Trial Update: B-Lymphocyte Immunotherapy in Islet Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating B-Lymphocyte Immunotherapy in islet transplantation for Type 1 Diabetes Mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• B-Lymphocyte Immunotherapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: TERMINATED